Anagrammer
Our Word SolversWord Lists

Crossword Solver > found answer > YMBIOT

Welcome to Anagrammer Crossword Genius! Keep reading below to see if ymbiot is an answer to any crossword puzzle or word game (Scrabble, Words With Friends etc). Scroll down to see all the info we have compiled on ymbiot.

CROSSWORD
ANSWER

ymbiot

Searching in Crosswords ...

The answer YMBIOT has 0 possible clue(s) in existing crosswords.

Searching in Word Games ...

The word YMBIOT is NOT valid in any word game. (Sorry, you cannot play YMBIOT in Scrabble, Words With Friends etc)

There are 6 letters in YMBIOT ( B3I1M3O1T1Y4 )

To search all scrabble anagrams of YMBIOT, to go: YMBIOT

Rearrange the letters in YMBIOT and see some winning combinations

Scrabble results that can be created with an extra letter added to YMBIOT

SYMBIOT

4 letters out of YMBIOT

MITYOBITOMITTOBYTOMB

3 letters out of YMBIOT

BIOBITBOTBOYMIBMOBMOTOBITOMTOYYOBYOM

2 letters out of YMBIOT

BIBOBYITMIMOMYOIOMOYTITOYO

Searching in Dictionaries ...

Definitions of ymbiot in various dictionaries:

No definitions found

Word Research / Anagrams and more ...


Keep reading for additional results and analysis below.

Ymbiot might refer to
YM BioSciences Inc. was a Canadian drug development company primarily focused on advancing CYT-387, an orally administered inhibitor of both the JAK1 and JAK2 kinases, which have been implicated in a number of hematological and immune cell disorders including myeloproliferative neoplasms and inflammatory diseases as well as certain cancers. YM BioSciences also had several preclinical programs underway with candidates from its library of compounds identified through internal research conducted at YM BioSciences Australia.
* The company also advanced other clinical-stage products, including Nimotuzumab, an EGFR-targeting monoclonal antibody, and CYT997, a vascular disrupting agent (VDA).
* The company was listed on the Toronto Stock Exchange and the New York Stock Exchange.YM BioSciences was the first company from any major-market country to enter into a relationship with the Cuban Government for the development of a number of that country's biopharmaceuticals, with first licenses concluding in 1995. In 1994, the company created a joint venture with Centro de Inmunología Molecular (CCIMAB) in Cuba called CIMYM BioSciences. The joint venture developed the Nimotuzumab drug. In February 2013, Gilead Sciences completed the acquisition of YM Biosciences for US $510 million.
Anagrammer Crossword Solver is a powerful crossword puzzle resource site. We maintain millions of regularly updated crossword solutions, clues and answers of almost every popular crossword puzzle and word game out there. We encourage you to bookmark our puzzle solver as well as the other word solvers throughout our site. Explore deeper into our site and you will find many educational tools, flash cards and plenty more resources that will make you a much better player. Ymbiot: YM BioSciences Inc. was a Canadian drug development company primarily focused on advancing CYT-387, ...